Recon: FDA rejects AbbVie Parkinson’s treatment over manufacturing concerns; AstraZeneca’s Imfinzi fails in Phase 3 lung cancer trial
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States